Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Chitodex Gel Vs NexFoam on Post-operative Outcomes in the Treatment of Chronic Rhinosinusitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Those who have had symptoms of chronic rhinosinusitis (nasal discharge, postnasal drip, nasal obstruction, facial pain and pressure, lack of sense of smell) that has been previously persistent for greater than 3 months AND~2. ≥ 18 years to ≤ 90 years AND~3. English speaking AND~4. Able to give written informed consent AND~5. Local residents who will be returning to this center for postoperative follow-up care AND~6. Indicated to undergo endoscopic sinus surgery and willing to return at 2-4, 6-8 \& 12 (± 2) weeks post-op.~Exclusion Criteria:~1. allergy to shellfish~2. pregnant or breastfeeding~3. Hepatitis or blood disorders~4. any drug allergy~5. allergy to potato starch (due to Nexfoam)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Chitogel (Type: None): Chitodex gel plus Kenalog inserted into the middle meatus
- Nexfoam (Type: None): NexFoam plus Kenalog inserted into the middle meatus

Based on this trial design, predict the completion outcome and termination type (if applicable).